Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
J Gastroenterol Hepatol ; 24(8): 1358-64, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19467141

RESUMO

BACKGROUND AND AIM: Self-expandable metallic stent placement is accepted as palliative therapy for advanced gastric cancer with gastric outlet obstruction, but data are lacking for chemotherapy after self-expandable metallic stent insertion. This study retrospectively compared results between surgery plus chemotherapy and stenting plus chemotherapy for metastatic gastric cancer with pyloric stenosis. METHODS: Subjects comprised 26 patients who received chemotherapy after surgery or endoscopic stenting for metastatic gastric cancer with pyloric stenosis between April 2000 and December 2007 in four Japanese hospitals. Patients were categorized into two groups: 15 patients who received chemotherapy after surgery for pyloric stenosis (Surgery group); and 11 patients who received chemotherapy after self-expandable metallic stent placement for pyloric stenosis (Stent group). RESULTS: Median survival time and median time to treatment failure were 284 days and 226 days in the Surgery group and 337 days and 247 days in the Stent group, respectively. No significant differences were noted between survival and time to treatment failure. No significant differences were found in median oral intake rate (Surgery, 93.1%; Stent, 93.2%) or median hospital stay rate (Surgery, 24.6%; Stent, 23.7%) during survival. Response rate was 45.5% in the Surgery group and 50% in the Stent group, with no significant difference. Likewise, no significant differences were noted between groups for frequencies of toxicity or complications. CONCLUSIONS: The present results suggest that chemotherapy after stenting is as effective and safe as chemotherapy after surgery. Stents may replace surgery in combination therapy with chemotherapy for metastatic gastric cancer with gastric outlet obstruction.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Gastrectomia , Gastroscopia , Metais , Estenose Pilórica/etiologia , Stents , Neoplasias Gástricas/tratamento farmacológico , Neoplasias Gástricas/cirurgia , Adulto , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Quimioterapia Adjuvante , Ingestão de Alimentos , Estudos de Viabilidade , Feminino , Gastrectomia/efeitos adversos , Derivação Gástrica , Gastroscopia/efeitos adversos , Humanos , Japão , Estimativa de Kaplan-Meier , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Cuidados Paliativos , Desenho de Prótese , Estenose Pilórica/tratamento farmacológico , Estenose Pilórica/mortalidade , Estenose Pilórica/cirurgia , Estudos Retrospectivos , Medição de Risco , Neoplasias Gástricas/complicações , Neoplasias Gástricas/mortalidade , Neoplasias Gástricas/secundário , Fatores de Tempo , Falha de Tratamento
2.
Am J Med Genet ; 93(3): 181-3, 2000 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-10925377

RESUMO

We report on two sisters with facial anomalies, protein-losing enteropathy, and intestinal lymphangiectasia consistent with the diagnosis of Hennekam syndrome. Both patients had a number of other anomalies not previously described in this autosomal recessive disorder, i.e., primary hypothyroidism, hypertrophic pyloric stenosis, and an early fatal outcome. These cases support the autosomal recessive transmission and the expansion of the phenotype of the Hennekam syndrome.


Assuntos
Anormalidades Múltiplas/genética , Anormalidades Múltiplas/mortalidade , Anormalidades Múltiplas/diagnóstico , Anormalidades Múltiplas/patologia , Face/anormalidades , Face/patologia , Saúde da Família , Feminino , Genes Recessivos , Humanos , Hipotireoidismo/genética , Hipotireoidismo/mortalidade , Hipotireoidismo/patologia , Lactente , Intestinos/anormalidades , Intestinos/patologia , Fenótipo , Enteropatias Perdedoras de Proteínas/genética , Enteropatias Perdedoras de Proteínas/mortalidade , Enteropatias Perdedoras de Proteínas/patologia , Estenose Pilórica/genética , Estenose Pilórica/mortalidade , Estenose Pilórica/patologia , Síndrome
3.
Eur J Pediatr Surg ; 10(6): 365-7, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11215776

RESUMO

Between 1919 and 1941, 71 infants suffering from pyloric hypertrophy were operated on by Ramstedt performing an extramucosal pyloromyotomy. Of these patients, we could identify and investigate 41. Four out of 31 long-term surviving patients have been Billroth II-resected (BII). One of these needed re-resection because of an anastomotic ulcer. None of all the long-term survivors developed a carcinoma. Two patients were treated conservatively because of gastritis and one because of esophagitis. All patients, except the one requiring re-resection and one suffering from maldigestion, were absolutely free of complaints. The average time between operation and re-checking was 57 years. The oldest patient was examined 72 years after the operation.


Assuntos
Estenose Pilórica/congênito , Piloro/cirurgia , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Hipertrofia , Lactente , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/mortalidade , Complicações Pós-Operatórias/cirurgia , Estenose Pilórica/mortalidade , Estenose Pilórica/cirurgia , Reoperação , Estudos Retrospectivos , Instrumentos Cirúrgicos , Taxa de Sobrevida
4.
Scott Med J ; 26(3): 245-9, 1981 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7268400

RESUMO

A brief review of the development of the surgical management of infantile hypertrophic pyloric stenosis is made. The incidence, investigation, management and complications of cases treated at the Royal Hospital for Sick Children, Glasgow over a period of six decades is reported. The mortality fell from 59 per cent in 1925 to 0 per cent in 1975. Pyloromyotomy in infants with hypertrophic pyloric stenosis is shown to be a very effective treatment for this potentially lethal condition and must rank as one of the most cost-effective forms of treatment in medical practice.


Assuntos
Estenose Pilórica/cirurgia , Feminino , Humanos , Hipertrofia , Lactente , Masculino , Complicações Pós-Operatórias , Estenose Pilórica/mortalidade , Piloro/cirurgia
5.
Pediatrics ; 130(6): 1084-93, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23129078

RESUMO

OBJECTIVES: To examine hospitalizations and length of stay (LOS) for infants aged <1 year in rural and urban counties, hypothesizing that infants living in rural counties experience significantly different hospital use compared with urban infants. METHODS: Birth certificates for infants born in California hospitals between 1993 and 2005 and surviving to discharge were linked to hospital discharge records and death certificates during the first year of life, resulting in a study population of >6.4 million. Hospitalizations, cumulative LOS, readmission rates, and mortality were compared by using univariate and multivariable analysis for infants living in small rural, large rural, small urban, and large urban counties. Odds of hospitalization and cumulative LOS were also examined for common infant diagnoses. RESULTS: Infants living in increasingly rural counties experienced decreasing rates of hospitalization and decreasing number of hospitalized days during the first year of life. Infants living in small rural counties experienced 370 hospital days per 1000 infants compared with 474 hospital days per 1000 infants living in large urban counties. In multivariable analysis, infants in large urban counties experienced increased odds of hospitalization (odds ratio: 1.20 [95% confidence interval: 1.06-1.36]) and increased hospitalized days (incidence risk ratio: 1.17 [95% confidence interval: 1.06-1.29]) compared with infants in small rural counties. For most common diagnoses, urban residence was associated with either increased odds of hospitalization or increased cumulative LOS. CONCLUSIONS: Infants living in rural California counties experienced decreased hospital utilization, including decreased hospitalization and decreased LOS, compared with infants living in urban counties.


Assuntos
Hospitalização/estatística & dados numéricos , População Rural/estatística & dados numéricos , População Urbana/estatística & dados numéricos , Peso ao Nascer , California , Feminino , Idade Gestacional , Pesquisa sobre Serviços de Saúde/estatística & dados numéricos , Mortalidade Hospitalar , Humanos , Lactente , Recém-Nascido , Doenças do Prematuro/epidemiologia , Doenças do Prematuro/mortalidade , Recém-Nascido Pequeno para a Idade Gestacional , Cobertura do Seguro/estatística & dados numéricos , Classificação Internacional de Doenças , Icterícia Neonatal/epidemiologia , Icterícia Neonatal/mortalidade , Tempo de Internação/estatística & dados numéricos , Masculino , Análise Multivariada , Razão de Chances , Readmissão do Paciente/estatística & dados numéricos , Estenose Pilórica/epidemiologia , Estenose Pilórica/mortalidade , Sepse/epidemiologia , Sepse/mortalidade , Meio Social , Fatores Socioeconômicos , Análise de Sobrevida , Revisão da Utilização de Recursos de Saúde/estatística & dados numéricos
17.
J Paediatr Child Health ; 42(3): 86-8, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16509905

RESUMO

Good outcome following pyloromyotomy for pyloric stenosis is dependent on the training of the surgeon, availability of a specialist paediatric anaesthetist, and the quality of preoperative correction of fluid and electrolyte abnormalities. Complications (including death, inadvertent duodenal perforation, incomplete pyloromyotomy, wound dehiscence and infection), higher hospital costs and increased length of hospital stay are all more likely to occur when the pyloromyotomy is performed by a surgeon who has had no speciailist paediatric surgical training.


Assuntos
Procedimentos Cirúrgicos do Sistema Digestório/métodos , Pediatria/normas , Estenose Pilórica/cirurgia , Resultado do Tratamento , Anestesia , Criança , Pré-Escolar , Competência Clínica , Procedimentos Cirúrgicos do Sistema Digestório/efeitos adversos , Humanos , Lactente , Tempo de Internação , Pediatria/métodos , Complicações Pós-Operatórias , Estenose Pilórica/complicações , Estenose Pilórica/mortalidade , Infecção da Ferida Cirúrgica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA